UPDATE : Friday, January 17, 2020
Regulator to consider re-classifying choline alfoscerate as functional food by Kim Yun-mi 2019-11-06 13:54
Daewoong to sell Merck's cardiovascular disease treatment by Lee Han-soo 2019-11-05 15:05
Merck Korea hurries to close GM part despite union’s protest by Kim Yun-mi 2019-11-05 15:04
[Interview with global pharmas] 'Pfizer Korea combines Pfizer's outstanding innovation with Koreans’ talents' by Lee Han-soo 2019-11-05 12:46
Yuhan, Dong-A, HanAll see Q3 earnings jump on licensing-out deals by Jeong Sae-im 2019-11-04 15:52
Takeda Korea fires union leader to worsen labor-management dispute by Kim Yun-mi 2019-11-04 15:03
Hanmi’s oral anticancer treatment becomes orphan drug in Europe by Lee Han-soo 2019-11-01 17:50
Life Semantics to unveil its digital drug pipeline next week by Lee Han-soo 2019-11-01 16:55
Daewon gets nod to sell Richter-Helm Biotec's osteoporosis biosimilar by Lee Han-soo 2019-11-01 16:08
Regulator grants certification to global vaccine organ by Lee Han-soo 2019-11-01 16:07
Kolon allegedly knew Inovossa mislabeling before applying for approval by Jeong Sae-im 2019-11-01 15:07
Novartis’ breast cancer treatment wins regulator’s nod by Lee Han-soo 2019-10-31 17:35
GSK Korea releases toddler vaccine Infanrix IPV-Hib by Lee Han-soo 2019-10-31 14:49
Merck Biopharma Korea launches infertility treatment Pergoveris Pen by Lee Han-soo 2019-10-31 14:31
Huons’ insomnia cure, 2 other drugs to win insurance benefit by Kim Yun-mi 2019-10-31 13:22
GC's Jan.-Sept. sales top ₩1 trillion by Lee Han-soo 2019-10-30 18:26
AbbVie’s new psoriasis drug likely to win nod this year by Kim Yun-mi 2019-10-30 16:05
71 pharmaceutical CEOs gather to boost new drug development by Jeong Sae-im 2019-10-30 12:40
AstraZeneca wins expanded indication for anticancer treatment Lynparza by Lee Han-soo 2019-10-30 12:39
Hanmi’s Q3 sales rise 13% by Lee Han-soo 2019-10-29 16:04
Back to Top